ALEMBIC Revenue vs. Beta

<div class='circular--portrait' style='background:#FF01C9;color: #FFF8DC;font-size:3em;padding-top: 38px;;'>ALE</div>
The Drivers Module shows relationships between ALEMBIC's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of ALEMBIC LTD over time as well as its relative position and ranking within its peers. Check out Trending Equities.

Search Current Fundamental Trends


ALEMBIC LTD Beta vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining ALEMBIC's current stock value. Our valuation model uses many indicators to compare ALEMBIC value to that of its competitors to determine the firm's financial worth.
ALEMBIC LTD is the top company in revenue category among related companies. It is number one stock in beta category among related companies . The ratio of Revenue to Beta for ALEMBIC LTD is about  1,132,743,363 
ALEMBIC LTD is the top company in revenue category among related companies. Market size based on revenue of Drug Manufacturers - Specialty & Generic industry is presently estimated at about 2.56 Billion. ALEMBIC totals roughly 1.28 Billion in revenue claiming about 50% of equities under Drug Manufacturers - Specialty & Generic industry.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and is an essential item when evaluating financial statements of a company. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Money Received 
Discounts and Returns 
1.28 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it will be expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

ALEMBIC Beta Comparison

Beta Analysis

Let's try to break down what ALEMBIC's beta means in this case. ALEMBIC returns are very sensitive to returns on the market. As the market goes up or down, ALEMBIC is expected to follow.

ALEMBIC Fundamental Comparison

Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page